Published in
Oxford University Press, The Journal of Infectious Diseases, 11(226), p. 1909-1912, 2022
Links
Tools
Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity
Journal article published in 2022 by
Annika Rössler,
Janine Kimpel,
Verena Fleischer,
Silke Huber,
Dorothee von Laer,
Wegene Borena 
,
Reinhard Würzner,
David Bante,
Barbara Falkensammer,
Helena Schäfer,
Florian Krammer,
Peter Pichler,
Ursula Wiedermann,
Daniel Rainer,
Tobias Trips
and other authors.
,
Reinhard Würzner,
David Bante,
Barbara Falkensammer,
Helena Schäfer,
Florian Krammer,
Peter Pichler,
Ursula Wiedermann,
Daniel Rainer,
Tobias Trips
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Abstract We investigated antibody titers and avidity after heterologous versus homologous coronavirus disease 2019 vaccination over 6 months after the second dose. We found a significantly higher avidity in regimens including at least 1 dose of the adenoviral vector vaccine ChAdOx1-S compared with 2 doses of the mRNA vaccine BNT162b2.